| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/30/1997 | US5672347 Administering in therapeutically effective dosage to suppress transplantation immunity |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/30/1997 | CA2177217A1 Compositions and methods for production of male-sterile plants |
| 09/25/1997 | WO1997035204A1 Method for predicting the outcome of hepatitis b infection |
| 09/25/1997 | WO1997035199A1 Azatide peptidomimetics |
| 09/25/1997 | WO1997035037A1 Tissue remodeling proteins |
| 09/25/1997 | WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells |
| 09/25/1997 | WO1997035015A2 Tyrosine-phosphatase-related protein |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997035004A1 Cell stimulation |
| 09/25/1997 | WO1997034931A1 Antibody specific for staphylococcus aureus, and use thereof |
| 09/25/1997 | WO1997034912A1 Directed switch-mediated dna recombination |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/25/1997 | WO1997034635A1 Anti-idiotypic antibody vaccines |
| 09/25/1997 | WO1997034634A1 Single chain fv constructs of anti-ganglioside gd2 antibodies |
| 09/25/1997 | WO1997034633A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/25/1997 | WO1997034632A1 Glycosylated humanized b-cell specific antibodies |
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034630A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | WO1997034616A1 A method for periodontal disease treatment |
| 09/25/1997 | WO1997034501A1 Folate receptor-directed metalloproteases and methods for using same |
| 09/25/1997 | WO1997022363A3 Improved pharmaceutical compositions |
| 09/25/1997 | WO1997020048A3 Modified SFV molecules which mediate adhesion between cells and uses thereof |
| 09/25/1997 | WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | DE19634159C1 Hybrid cells prepared by fusing malignant B cells with hybridoma that expresses antibodies |
| 09/25/1997 | CA2283633A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | CA2250076A1 Method for predicting the outcome of hepatitis b infection |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249195A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2243509A1 Anti-idiotypic antibody vaccines |
| 09/25/1997 | CA2221591A1 Tissue remodeling proteins |
| 09/24/1997 | EP0796334A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof |
| 09/24/1997 | EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796321A1 E2 binding proteins |
| 09/24/1997 | EP0796320A1 Human dna ligase iii |
| 09/24/1997 | EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/24/1997 | EP0796279A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 09/24/1997 | EP0796277A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796274A2 Chromosome 21 gene marker, compositions and methods using same |
| 09/24/1997 | EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 09/24/1997 | CN1160420A Pesticidal proteins and strains |
| 09/23/1997 | US5670645 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 09/23/1997 | US5670637 Binding to target molecules; antibodies |
| 09/23/1997 | US5670627 Immunoassay |
| 09/23/1997 | US5670626 Allergen-specific human IgA monoclonal antibodies for mucosal administration |
| 09/23/1997 | US5670625 Cell surface protein |
| 09/23/1997 | US5670623 Methods of use of cellulose binding domain proteins |
| 09/23/1997 | US5670621 Selectively recognizes and binds dna damaged by a drug |
| 09/23/1997 | US5670477 Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents |
| 09/23/1997 | US5670362 DNA encoding an Eimeria 100kD antigen |
| 09/23/1997 | US5670337 Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof |
| 09/23/1997 | US5670328 Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof |
| 09/23/1997 | US5670319 Assay for tumor necrosis factor receptor-associated factors |
| 09/23/1997 | US5670317 Using a protein |
| 09/23/1997 | US5670312 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670150 Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM) |
| 09/23/1997 | US5670132 Polyoxyethylene glycol and technetium labeled fab fragments for labeled antibodies |
| 09/23/1997 | US5669819 Immunoassay |
| 09/23/1997 | US5669396 Blood test; using antibodies |
| 09/23/1997 | CA1339469C Production and characteristics of anti-anti-cea antibody |
| 09/18/1997 | WO1997034145A1 Antiphosphorylated tau protein antibody and method for detecting alzheimer's disease with the use of the same |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033917A1 Antibodies for detecting cytosine deaminase |
| 09/18/1997 | WO1997033916A1 Monoclonal antibodies ior c5 for the diagnosis and treatment of colorectal tumors |
| 09/18/1997 | WO1997033915A1 Avian, vitellin antibodies directed against hiv antigens |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033618A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/18/1997 | WO1997033617A1 Fas ligand fusion proteins and their uses |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033607A1 Orally-administered interferon-tau compositions and methods |
| 09/18/1997 | WO1997033606A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033466A1 Non-genetically modified mammal as a model for multiple sclerosis |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | DE19610119A1 Antikörper zum Nachweis von Cytosin Deaminase Antibodies for the detection of cytosine deaminase |
| 09/18/1997 | CA2249182A1 Death domain containing receptors |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248551A1 Programmed cell death and interleukin-1.beta. |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |